Publications

This fact sheet provides information to help support the correct billing of Medicare Benefits Schedule Items (MBS) 18222 and 18225 for regional or field nerve blocks.

Health professionals can print this fact sheet and give it to patients who are starting treatment under the Life Saving Drugs Program.

This fact sheet gives answers to common questions about the role of pharmacies and authorised persons in managing Life Saving Drugs Program (LSDP) medicines.

This fact sheet gives answers to common questions about the role of treating physicians in prescribing Life Saving Drugs Program (LSDP) medicines.

Use this form to help transition a patient’s care to a new physician, where there are no other changes to their treatment or eligibility for the Life Saving Drugs Program (LDSP).

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This fact sheet provides our position on the hospital treatment certification.

This document looks at the improvements to the National Framework for Alcohol, Tobacco and other Drug Treatment. It looks at improving processes for communication, coordination, and collaboration (CCC) between and amongst alcohol and other drug (AOD) treatment funders.

This report lists the percentage of people who have self identified as Indigenous who have been vaccinated against COVID-19, by SA4. The percentages are further broken down by geographic regions and whether they've had one dose or are fully vaccinated.

These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA).

This presentation, delivered on 25 January 2023, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This suite of materials for the 'Japanese encephalitis virus' campaign encourages Australians to cover up, use insect repellent and use a screen or net.

This poster provides key differences between each COVID-19 vaccine approved for use in Australia as per the Australian Technical Advisory Group on Immunisation (ATAGI) guidelines.

This fact sheet explains the separate funding class for individuals who enter residential care for the purpose of receiving palliative care.

This infographic issued on 27 January 2023 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia.

This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health.

This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This user guide explains to administrators how to use the My Aged Care service and support portal.

This document outlines the terms of use for the Government Provider Management System (GPMS). The GPMS allows aged care service providers to see their Star Ratings.

A list of National Health and Medical Research Council (NHMRC) projects and the committed funding.